Cardiovascular and mortality outcomes in the elderly with impaired cardiac and pulmonary function

The Cardiovascular Health Study (CHS)

Salman Waheed, Paulo H M Chaves, Julius M. Gardin, Jie Jane Cao

Research output: Contribution to journalArticle

Abstract

Background-Impaired pulmonary function (IPF) and left ventricular systolic dysfunction (LVSD) are prevalent in the elderly and are associated with significant morbidity and mortality. The main objectives of this study were to examine the relative impact and joint association of IPF and LVSD with heart failure, cardiovascular mortality and all-cause mortality, and their impact on risk classification using a continuous net reclassification index. Methods and Results-We followed 2342 adults without prevalent cardiovascular disease (mean age, 76 years) from the Cardiovascular Health Study for a median of 12.6 years. LVSD was defined as LV ejection fraction < 55%. IPF was defined as: Forced expiratory volume in 1 second:forced vital capacity < 70%, and predicted forced expiratory volume in 1 second < 80%. Outcomes included heart failure hospitalization, cardiovascular mortality, all-cause mortality, and composite outcome. LVSD was detected in 128 subjects (6%), IPF in 441 (19%) and both in 38 (2%). Compared to those without LVSD or IPF, there was a significantly increased cardiovascular risk for groups of LVSD only, IPF only, and LVSD plus IPF, adjusted hazard ratio (95% CI) 2.1 (1.5-3.0), 1.7 (1.4-2.1), and 3.2 (2.0-5.1) for HF; 1.8 (1.2-2.6), 1.4 (1.1-1.8), and 2.8 (1.7-4.7) for cardiovascular mortality; 1.3 (1.0-1.8), 1.7 (1.4-1.9), and 2.1 (1.5-3.0) for all-cause mortality, and 1.6 (1.3-2.1), 1.7 (1.5-1.9), and 2.4 (1.7-3.3) for composite outcome, respectively. Risk classification improved significantly for all outcomes when IPF was added to the adjusted model with LVSD or LVSD to IPF. Conclusions-While risk of cardiovascular outcomes was the highest among elderly with both LVSD and IPF, risk was comparable between subjects with IPF alone and those with LVSD alone. This observation, combined with improved risk classification by adding IPF to LVSD or LVSD to IPF, underscore the importance of comprehensive heart and lung evaluation in cardiovascular outcome assessment.

Original languageEnglish (US)
Article numbere002308
JournalJournal of the American Heart Association
Volume4
Issue number12
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

Left Ventricular Dysfunction
Lung
Mortality
Health
Forced Expiratory Volume
Heart Failure
Vital Capacity
Hospitalization
Cardiovascular Diseases
Outcome Assessment (Health Care)

Keywords

  • Elderly
  • Epidemiology
  • Heart failure
  • Left ventricular systolic dysfunction
  • Mortality
  • Pulmonary function

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiovascular and mortality outcomes in the elderly with impaired cardiac and pulmonary function : The Cardiovascular Health Study (CHS). / Waheed, Salman; Chaves, Paulo H M; Gardin, Julius M.; Cao, Jie Jane.

In: Journal of the American Heart Association, Vol. 4, No. 12, e002308, 01.12.2015.

Research output: Contribution to journalArticle

@article{84740c8a619a4969aa78e779af62a2e2,
title = "Cardiovascular and mortality outcomes in the elderly with impaired cardiac and pulmonary function: The Cardiovascular Health Study (CHS)",
abstract = "Background-Impaired pulmonary function (IPF) and left ventricular systolic dysfunction (LVSD) are prevalent in the elderly and are associated with significant morbidity and mortality. The main objectives of this study were to examine the relative impact and joint association of IPF and LVSD with heart failure, cardiovascular mortality and all-cause mortality, and their impact on risk classification using a continuous net reclassification index. Methods and Results-We followed 2342 adults without prevalent cardiovascular disease (mean age, 76 years) from the Cardiovascular Health Study for a median of 12.6 years. LVSD was defined as LV ejection fraction < 55{\%}. IPF was defined as: Forced expiratory volume in 1 second:forced vital capacity < 70{\%}, and predicted forced expiratory volume in 1 second < 80{\%}. Outcomes included heart failure hospitalization, cardiovascular mortality, all-cause mortality, and composite outcome. LVSD was detected in 128 subjects (6{\%}), IPF in 441 (19{\%}) and both in 38 (2{\%}). Compared to those without LVSD or IPF, there was a significantly increased cardiovascular risk for groups of LVSD only, IPF only, and LVSD plus IPF, adjusted hazard ratio (95{\%} CI) 2.1 (1.5-3.0), 1.7 (1.4-2.1), and 3.2 (2.0-5.1) for HF; 1.8 (1.2-2.6), 1.4 (1.1-1.8), and 2.8 (1.7-4.7) for cardiovascular mortality; 1.3 (1.0-1.8), 1.7 (1.4-1.9), and 2.1 (1.5-3.0) for all-cause mortality, and 1.6 (1.3-2.1), 1.7 (1.5-1.9), and 2.4 (1.7-3.3) for composite outcome, respectively. Risk classification improved significantly for all outcomes when IPF was added to the adjusted model with LVSD or LVSD to IPF. Conclusions-While risk of cardiovascular outcomes was the highest among elderly with both LVSD and IPF, risk was comparable between subjects with IPF alone and those with LVSD alone. This observation, combined with improved risk classification by adding IPF to LVSD or LVSD to IPF, underscore the importance of comprehensive heart and lung evaluation in cardiovascular outcome assessment.",
keywords = "Elderly, Epidemiology, Heart failure, Left ventricular systolic dysfunction, Mortality, Pulmonary function",
author = "Salman Waheed and Chaves, {Paulo H M} and Gardin, {Julius M.} and Cao, {Jie Jane}",
year = "2015",
month = "12",
day = "1",
doi = "10.1161/JAHA.115.002308",
language = "English (US)",
volume = "4",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Cardiovascular and mortality outcomes in the elderly with impaired cardiac and pulmonary function

T2 - The Cardiovascular Health Study (CHS)

AU - Waheed, Salman

AU - Chaves, Paulo H M

AU - Gardin, Julius M.

AU - Cao, Jie Jane

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Background-Impaired pulmonary function (IPF) and left ventricular systolic dysfunction (LVSD) are prevalent in the elderly and are associated with significant morbidity and mortality. The main objectives of this study were to examine the relative impact and joint association of IPF and LVSD with heart failure, cardiovascular mortality and all-cause mortality, and their impact on risk classification using a continuous net reclassification index. Methods and Results-We followed 2342 adults without prevalent cardiovascular disease (mean age, 76 years) from the Cardiovascular Health Study for a median of 12.6 years. LVSD was defined as LV ejection fraction < 55%. IPF was defined as: Forced expiratory volume in 1 second:forced vital capacity < 70%, and predicted forced expiratory volume in 1 second < 80%. Outcomes included heart failure hospitalization, cardiovascular mortality, all-cause mortality, and composite outcome. LVSD was detected in 128 subjects (6%), IPF in 441 (19%) and both in 38 (2%). Compared to those without LVSD or IPF, there was a significantly increased cardiovascular risk for groups of LVSD only, IPF only, and LVSD plus IPF, adjusted hazard ratio (95% CI) 2.1 (1.5-3.0), 1.7 (1.4-2.1), and 3.2 (2.0-5.1) for HF; 1.8 (1.2-2.6), 1.4 (1.1-1.8), and 2.8 (1.7-4.7) for cardiovascular mortality; 1.3 (1.0-1.8), 1.7 (1.4-1.9), and 2.1 (1.5-3.0) for all-cause mortality, and 1.6 (1.3-2.1), 1.7 (1.5-1.9), and 2.4 (1.7-3.3) for composite outcome, respectively. Risk classification improved significantly for all outcomes when IPF was added to the adjusted model with LVSD or LVSD to IPF. Conclusions-While risk of cardiovascular outcomes was the highest among elderly with both LVSD and IPF, risk was comparable between subjects with IPF alone and those with LVSD alone. This observation, combined with improved risk classification by adding IPF to LVSD or LVSD to IPF, underscore the importance of comprehensive heart and lung evaluation in cardiovascular outcome assessment.

AB - Background-Impaired pulmonary function (IPF) and left ventricular systolic dysfunction (LVSD) are prevalent in the elderly and are associated with significant morbidity and mortality. The main objectives of this study were to examine the relative impact and joint association of IPF and LVSD with heart failure, cardiovascular mortality and all-cause mortality, and their impact on risk classification using a continuous net reclassification index. Methods and Results-We followed 2342 adults without prevalent cardiovascular disease (mean age, 76 years) from the Cardiovascular Health Study for a median of 12.6 years. LVSD was defined as LV ejection fraction < 55%. IPF was defined as: Forced expiratory volume in 1 second:forced vital capacity < 70%, and predicted forced expiratory volume in 1 second < 80%. Outcomes included heart failure hospitalization, cardiovascular mortality, all-cause mortality, and composite outcome. LVSD was detected in 128 subjects (6%), IPF in 441 (19%) and both in 38 (2%). Compared to those without LVSD or IPF, there was a significantly increased cardiovascular risk for groups of LVSD only, IPF only, and LVSD plus IPF, adjusted hazard ratio (95% CI) 2.1 (1.5-3.0), 1.7 (1.4-2.1), and 3.2 (2.0-5.1) for HF; 1.8 (1.2-2.6), 1.4 (1.1-1.8), and 2.8 (1.7-4.7) for cardiovascular mortality; 1.3 (1.0-1.8), 1.7 (1.4-1.9), and 2.1 (1.5-3.0) for all-cause mortality, and 1.6 (1.3-2.1), 1.7 (1.5-1.9), and 2.4 (1.7-3.3) for composite outcome, respectively. Risk classification improved significantly for all outcomes when IPF was added to the adjusted model with LVSD or LVSD to IPF. Conclusions-While risk of cardiovascular outcomes was the highest among elderly with both LVSD and IPF, risk was comparable between subjects with IPF alone and those with LVSD alone. This observation, combined with improved risk classification by adding IPF to LVSD or LVSD to IPF, underscore the importance of comprehensive heart and lung evaluation in cardiovascular outcome assessment.

KW - Elderly

KW - Epidemiology

KW - Heart failure

KW - Left ventricular systolic dysfunction

KW - Mortality

KW - Pulmonary function

UR - http://www.scopus.com/inward/record.url?scp=84991523045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991523045&partnerID=8YFLogxK

U2 - 10.1161/JAHA.115.002308

DO - 10.1161/JAHA.115.002308

M3 - Article

VL - 4

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 12

M1 - e002308

ER -